These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2943796)

  • 61. Identification and characterization of a functional receptor for interferon-gamma on a megakaryocytic cell line.
    Monté D; Wietzerbin J; Pancré V; Merlin G; Greenberg SM; Kusnierz JP; Capron A; Auriault C
    Blood; 1991 Oct; 78(8):2062-9. PubMed ID: 1832999
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The mutual effect of dehydroepiandrosterone and dexamethasone on interleukin-8 release from human peripheral blood mononuclear cells cultured in vitro.
    Komorowski J; Jazdzyk W; Stepień H
    Horm Metab Res; 1996 Oct; 28(10):570-1. PubMed ID: 8934219
    [No Abstract]   [Full Text] [Related]  

  • 63. Enrichment and initial characterization of the solubilized receptor for mouse gamma interferon.
    Hayes MP; Russell SW; Trotta PP; Basu M
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1096-105. PubMed ID: 2963631
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The interferon-gamma receptor on human monocytes, monocyte-like cell lines and polymorphonuclear leucocytes.
    Finbloom DS
    Biochem Soc Trans; 1990 Apr; 18(2):222-4. PubMed ID: 2143156
    [No Abstract]   [Full Text] [Related]  

  • 65. Ultrastructural effects of recombinant gamma-interferon on cultured human keratinocytes.
    Nickoloff BJ; Mahrle G; Morhenn V
    Ultrastruct Pathol; 1986; 10(1):17-21. PubMed ID: 2421470
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development of interferon-gamma antagonists as an example of biotechnology application to approach new immunomodulators.
    Garotta G; Ozmen L; Fountoulakis M
    Pharmacol Res; 1989; 21 Suppl 2():5-17. PubMed ID: 2534322
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Binding of 32P-labeled human recombinant immune interferon to U937 cells.
    Rashidbaigi A; Kung HF; Pestka S
    Methods Enzymol; 1986; 119():315-21. PubMed ID: 2945073
    [No Abstract]   [Full Text] [Related]  

  • 68. Gamma interferon modulation of prostaglandin E2 release from monocytes stimulated with lipopolysaccharides from Bacteroides intermedius, Bacteroides gingivalis, and Salmonella typhimurium.
    Garrison SW; Nichols FC
    Oral Microbiol Immunol; 1988 Sep; 3(3):138-43. PubMed ID: 3152029
    [No Abstract]   [Full Text] [Related]  

  • 69. Relative Adrenal Insufficiency in Pediatric Septic Shock.
    Vila-Pérez D; Jordan-García I
    J Pediatr Intensive Care; 2015 Sep; 4(3):129-137. PubMed ID: 31110862
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Glucocorticoids regulate natural killer cell function epigenetically.
    Eddy JL; Krukowski K; Janusek L; Mathews HL
    Cell Immunol; 2014 Jul; 290(1):120-30. PubMed ID: 24978612
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cortisol exerts bi-phasic regulation of inflammation in humans.
    Yeager MP; Pioli PA; Guyre PM
    Dose Response; 2011; 9(3):332-47. PubMed ID: 22013396
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin.
    Yeager MP; Rassias AJ; Pioli PA; Beach ML; Wardwell K; Collins JE; Lee HK; Guyre PM
    Crit Care Med; 2009 Oct; 37(10):2727-32. PubMed ID: 19885996
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Corticosteroid insufficiency in the critically ill. Pathomechanisms and recommendations for diagnosis and treatment].
    Briegel J; Vogeser M; Keh D; Marik P
    Anaesthesist; 2009 Feb; 58(2):122-33. PubMed ID: 19214457
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Cortisone substitution in sepsis. Is less more?].
    Briegel J
    Anaesthesist; 2003 Dec; 52 Suppl 1():S24-31. PubMed ID: 14727048
    [No Abstract]   [Full Text] [Related]  

  • 75. Stress-induced enhancement of skin immune function: A role for gamma interferon.
    Dhabhar FS; Satoskar AR; Bluethmann H; David JR; McEwen BS
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2846-51. PubMed ID: 10706626
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Glucocorticoids enhance concanavalin A-induced mitogenic response through the inhibition of nitric oxide production.
    Ramírez F; Silva A
    Immunology; 1997 Jan; 90(1):66-73. PubMed ID: 9038714
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of mycobacterial growth by the hypothalamus-pituitary-adrenal axis: differential responses of Mycobacterium bovis BCG-resistant and -susceptible mice.
    Brown DH; Sheridan J; Pearl D; Zwilling BS
    Infect Immun; 1993 Nov; 61(11):4793-800. PubMed ID: 8406880
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhancement of human monocyte beta-glucan receptors by glucocorticoids.
    Kay J; Czop JK
    Immunology; 1994 Jan; 81(1):96-102. PubMed ID: 8132226
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prostaglandin E2 selectively increases interferon gamma receptor expression on human CD8+ lymphocytes.
    elMasry MN; Rich RR
    J Clin Invest; 1989 Apr; 83(4):1436-40. PubMed ID: 2522938
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells.
    Snyers L; De Wit L; Content J
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2838-42. PubMed ID: 2157217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.